News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

This innovation Lab is an opportunity for businesses to overcome challenges by collaborating with academic experts in robotics and artificial intelligence (AI)

A call to interview managers and professionals working in drug discovery on their perspective on the development and use of AI in drug discovery.

Tools like ChatGPT and Bard promise to simplify the patent process, slashing costs and saving time. However, when it comes to safeguarding your intellectual property, these AI assistants can...

AI is a hot topic. Many life science and biomedical businesses are already using AI or exploring its potential to revolutionise the way they deliver their services. But it’s not all good n...

Explore the transformative impact of AI in healthcare and discover vital strategies for safeguarding AI-enhanced medical technologies within Europe's regulatory landscape. Gain insights into...

Marks & Clerk AI Report 2023 reveals an interesting insight into the latest trends in patent applications

Talking about AI/ChatGPT in HR and recruitment and how it's going to impact on recruitment and HR, with details relevant if you are reading this from the hiring side, or as a candidate.

Are you a scaling company looking to transform healthcare through data-driven innovation? Look no further than the Edinburgh University AI Accelerator Programme, delivered by The University ...

The “Flight Simulator for healthcare and life sciences” addresses staffing pressures, continuous learning demands and the pace of innovation in life sciences

At a time when the average cost of bringing a new drug to market is about $1.8 billion, according to a study led by the London School of Economics and published in the US in 2020, the value ...

Marks & Clerk recently released our 2022 annual report on artificial intelligence (AI) patent filing trends at the EPO. It provides some useful insights for the life and medical sciences sec...

Why aren’t the major pharmaceutical companies filing patents to AI-related inventions?

Sign up to our Newsletter

Subscribe

* indicates required

Our Valued Sponsors & Partners